Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fluphenazine decanoate 250mg/10ml inj vials
0402020L0AAAEAE
|
Fluphenazine decanoate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Fluphenazine decanoate 25mg/1ml inj pre-filled syringes
0402020L0AAAGAG
|
Fluphenazine decanoate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Fluphenazine decanoate 50mg/0.5ml inj ampoules
0402020L0AAABAB
|
Fluphenazine decanoate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Fluphenazine decanoate 50mg/2ml inj ampoules
0402020L0AAADAD
|
Fluphenazine decanoate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Fluphenazine decanoate 50mg/2ml inj pre-filled syringes
0402020L0AAAHAH
|
Fluphenazine decanoate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Flurazepam 15mg capsules
0401010L0AAAAAA
|
Flurazepam hydrochloride | Flurazepam hydrochloride | Central Nervous System | No data available |
|
Flurazepam 30mg capsules
0401010L0AAABAB
|
Flurazepam hydrochloride | Flurazepam hydrochloride | Central Nervous System | No data available |
|
Flurizin 10 tablets
0406000E0BCAAAB
|
Flurizin | Flunarizine dihydrochloride | Central Nervous System | No data available |
|
Flurizin 5 tablets
0406000E0BCABAD
|
Flurizin | Flunarizine dihydrochloride | Central Nervous System | No data available |
|
Fluvoxamine 50mg/5ml oral suspension
0403030L0AAAEAE
|
Fluvoxamine maleate | Fluvoxamine maleate | Central Nervous System | No data available |
|
Focalin XR 10mg capsules
0404000T0BBAAAA
|
Focalin XR | Dexmethylphenidate hydrochloride | Central Nervous System | No data available |
|
Focusim XL 10mg capsules
0404000M0BPAAAU
|
Focusim | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Focusim XL 20mg capsules
0404000M0BPABAQ
|
Focusim | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Focusim XL 30mg capsules
0404000M0BPACAV
|
Focusim | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Focusim XL 40mg capsules
0404000M0BPADAW
|
Focusim | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Foraven XL 150mg capsules
0403040W0BPABAE
|
Foraven | Venlafaxine | Central Nervous System | No data available |
|
Foraven XL 75mg capsules
0403040W0BPAAAD
|
Foraven | Venlafaxine | Central Nervous System | No data available |
|
Fortral 25mg tablets
0407020T0BBABAB
|
Fortral (Oral) | Pentazocine hydrochloride | Central Nervous System | No data available |
|
Fortral 30mg/1ml solution for injection ampoules
0407020U0BBAAAA
|
Fortral (Systemic) | Pentazocine lactate | Central Nervous System | No data available |
|
Fortral 50mg suppositories
0407020U0BBACAB
|
Fortral (Systemic) | Pentazocine lactate | Central Nervous System | No data available |
|
Fortral 60mg/2ml solution for injection ampoules
0407020U0BBABAC
|
Fortral (Systemic) | Pentazocine lactate | Central Nervous System | No data available |
|
Fosaprepitant 115mg powder for solution for infusion vials
0406000AEAAAAAA
|
Fosaprepitant | Fosaprepitant | Central Nervous System | No data available |
|
Fosaprepitant 150mg powder for solution for infusion vials
0406000AEAAABAB
|
Fosaprepitant | Fosaprepitant | Central Nervous System | No data available |
|
Fosphenytoin 750mg/10ml solution for injection vials
0408020U0AAAAAA
|
Fosphenytoin sodium | Fosphenytoin sodium | Central Nervous System | No data available |
|
Fremanezumab 225mg/1.5ml inj pre-filled syringes
0407042R0AAAAAA
|
Fremanezumab | Fremanezumab | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.